The event will have a mix of policymakers, national and international leaders from the pharma industry, MSME, innovators, academic and research fraternity
India accounts for more than half (almost 60%) of new leprosy cases worldwide, despite being declared ‘leprosy-free’ in 2005.
More than 120 speakers and 5,000 delegates are expected to attend
Experts will speak about primary tumours of the nervous system and also the tumours of other body parts which get metastasized to the nervous system
The researchers are of the view that the new drug designing strategy demonstrated by them could also be adopted to treat retroviral infections.
The hospital has recently launched Radionuclide therapy
This facility will integrate with existing Max hospitals and create a 2,300-bed contiguous medical hub spread over 23 acres. The first phase is to be ready by 2024
Participants also experienced a VR-enabled learning environment designed to support clinical skill development in controlled, repeatable, and risk-free settings
Board approves five-year appointment, subject to shareholder nod through postal ballot
DBT-BIRAC, BioE3 and the Rs 10,000-crore Biopharma SHAKTI scheme aim to accelerate innovation, biomanufacturing and exports
Subscribe To Our Newsletter & Stay Updated
